Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma

MLA

Louisa Stern, et al. “Efficacy and Safety of Palliative Treatment in Patients with Autoimmune Liver Disease-Associated Hepatocellular Carcinoma.” Annals of Hepatology, vol. 29, no. 6, Nov. 2024. EBSCOhost, https://doi.org/10.1016/j.aohep.2024.101534.

APA

Louisa Stern, Constantin Schmidt, Lorenz Kocheise, Vincent Joerg, Christian Casar, Aurélie Walter, Joost P.H. Drenth, Maria Papp, Nikolaos K. Gatselis, Kalliopi Zachou, Matthias Pinter, Bernhard Scheiner, Arndt Vogel, Martha M. Kirstein, Fabian Finkelmeier, Oliver Waidmann, Arndt Weinmann, Piotr Milkiewicz, Douglas Thorburn, … Kornelius Schulze. (2024). Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma. Annals of Hepatology, 29(6). https://doi.org/10.1016/j.aohep.2024.101534

Chicago

Louisa Stern, Constantin Schmidt, Lorenz Kocheise, Vincent Joerg, Christian Casar, Aurélie Walter, Joost P.H. Drenth, et al. 2024. “Efficacy and Safety of Palliative Treatment in Patients with Autoimmune Liver Disease-Associated Hepatocellular Carcinoma.” Annals of Hepatology 29 (6). doi:10.1016/j.aohep.2024.101534.